PROTEINE UND VERWENDUNGEN

Patent europeic · EP3529275 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3529275
Numer da la dumonda
EP17794919
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
23-10-2017
Publitgà
28-08-2019
Concedì
08-12-2021
La protecziun finescha il pli tard
22-10-2037
Proxima taxa annuala scadenta
31-10-2027
Classas IPC
C07K 16/24 (2006.01)
C07K 16/28 (2006.01)
Prioritad
GB 201617924 24.10.2016
Dumonda PCT
PCT/EP2017/076948 23.10.2017
Publicaziun PCT
WO2018/077775 03.05.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-11-2026

    Next annual fee due on

    Next annual fee due on
    31.10.2026 → 31.10.2027

    Published in Swissreg on 01.11.2026

  2. 01-11-2025

    Next annual fee due on

    Next annual fee due on
    31.10.2025 → 31.10.2026

    Published in Swissreg on 01.11.2025

  3. 01-11-2024

    Next annual fee due on

    Next annual fee due on
    31.10.2024 → 31.10.2025

    Published in Swissreg on 01.11.2024

  4. 01-11-2023

    Midada

    Published in Swissreg on 01.11.2023

  5. 01-11-2022

    Midada

    Published in Swissreg on 01.11.2022

  6. 19-10-2022

    Midada

    Published in Swissreg on 19.10.2022

  7. 08-12-2021

    Concedì

    Published in Swissreg on 08.12.2021

Partidas

Possessur

UCB Biopharma SRL

Allée de la Recherche 60, 1070 Brussels, BE

Inventur

BURNLEY, Rebecca

Slough Berkshire SL1 3WE, GB

WRIGHT, Michael John

Slough Berkshire SL1 3WE, GB

ETTORRE, Anna

Slough Berkshire SL1 3WE, GB

ADAMS, Ralph

Slough Berkshire SL1 3WE, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.